N@N

EPCT, DRRX, FLML, SMBL, ALSK, LOGM Expected To Be Down Before Next Earnings Releases

September 26, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. EPICEPT CORP (OTC:EPCT), DURECT CORPORATION (NASDAQ:DRRX), FLAMEL TECHNOLOGIES-SP ADR (NASDAQ:FLML), SMART BALANCE INC (NASDAQ:SMBL), ALASKA COMM SYSTEMS GROUP (NASDAQ:ALSK), LOGMEIN INC (NASDAQ:LOGM) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Tuesday:

     Symbol     Company                             # of Reports            Quarter     Release Date
     EPCT       EPICEPT CORP                        12 Quarter              Q3          11/08/2011
     DRRX       DURECT CORPORATION                  6 Quarter               Q3          11/03/2011
     FLML       FLAMEL TECHNOLOGIES-SP ADR          6 Quarter               Q3          11/03/2011
     SMBL       SMART BALANCE INC                   12 Quarter              Q3          11/03/2011
     ALSK       ALASKA COMM SYSTEMS GROUP           12 Quarter              Q3          10/27/2011
     LOGM       LOGMEIN INC                         6 Quarter               Q3          10/26/2011

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

EPICEPT CORP (OTC:EPCT) - EpiCept Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of cancer and pain in the United States and Germany. Its lead product, Ceplene, is used for the treatment of acute myeloid leukemia. The companys cancer portfolio includes Crinobulin, a small molecule vascular disruption agent (VDA) and apoptosis inducer, which is completed Phase I clinical trial for the treatment of patients with solid tumors; and Azixa, an apoptosis inducer under Phase II clinical trial product to treat the patients with primary glioblastoma and melanoma that has metastasized to the brain and non-small-cell lung cancer that has spread to the brain. Its late-stage pain product candidate, EpiCept NP-1 cream, is a prescription topical analgesic cream, which concluded a Phase II clinical trial designed to provide long-term relief of pain associated with peripheral neuropathies. The company also offers LidoPAIN BP, a prescription analgesic non-sterile patch designed to provide sustained topical delivery of lidocaine for the treatment of acute or recurrent lower back pain. It has license agreements with Meda AB; DURECT Corporation; Myriad Pharmaceuticals, Inc.; and Endo Pharmaceuticals Inc. EpiCept Corporation was formerly a subsidiary of Epic Resorts LLC. The company was founded in 1993 and is based in Tarrytown, New York.

DURECT CORPORATION (NASDAQ:DRRX) - DURECT Corporation focuses on the development of pharmaceutical products for pain, central nervous system disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulations and delivery platform technologies. Its products include Remoxy, an oxycodone gelatin capsule for chronic pain, which is accepted as a new drug application; POSIDUR, a release formulation of bupivacaine that is under Phase III clinical trial for post operative pain; ELADUR, a transdermal bupivacaine patch, which is under Phase II clinical trial, provides continuous delivery of bupivacaine for up to three days from a single application, as well as for the treatment of pain associated with post-herpetic neuralgia; and TRANSDUR-Sufentanil, a proprietary transdermal sufentanil patch, which is under Phase II clinical trial, provides continuous delivery of sufentanil for a period of up to seven days from a single application. The companys products also comprise oral controlled release opioid for pain that is under the Phase I clinical trial; and ORADUR-ADHD, a preclinical trial product targeting attention deficit hyperactivity disorder. It markets ALZET, the miniature implantable osmotic pumps and accessories for experimental research in mice, rats, and other laboratory animals. The company also develops and manufactures various biodegradable polymers based on lactide, glycolide, and caprolactone under the LACTEL brand for pharmaceutical and medical device clients, as well as conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. The company has strategic agreements with Alpharma Ireland Limited; Nycomed Danmark, ApS; Pain Therapeutics, Inc.; Endo Pharmaceuticals Inc; Curaxis Pharmaceutical Corporation; ALZA Corporation; EpiCept Corporation; NeuroSystec Corporation; and King Pharmaceuticals, Inc. DURECT Corporation was founded in 1998 and is based in Cupertino, California.

FLAMEL TECHNOLOGIES-SP ADR (NASDAQ:FLML) - Flamel Technologies S.A., a biopharmaceutical company, engages in the development of polymer-based drug delivery technologies for life science applications in France. The company develops products based on its nanoparticle Medusa technology, which provides controlled release following injection of therapeutic proteins, peptides, and other large and small molecules; multiparticle Micropump technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking, and bioavailability enhancement; and Trigger-Lock technology to minimize the misuse and abuse of medications subject to abuse. Its products under development based upon Medusa technology include Interferon-alpha, a naturally occurring protein that the body uses for the treatment of Hepatitis C virus; and FT-105 long-acting basal insulin formulation to meet the basal insulin requirements of diabetic patients. The companys products based on its Micropump technology comprise Trigger Lock, an application that provides a technical solution for the societal problems of intentional and unintentional abuse and misuse of narcotics and other dangerous drugs; and Coreg CR, a formulation of carvedilol phosphate, which is used for the treatment of moderate to severe congestive heart failure, left ventricular dysfunction following myocardial infarction, and hypertension. Flamel Technologies has strategic alliance with Baxter International, Inc.; GlaxoSmithKline; Merck Serono; Pfizer; Corning S.A; and Corning Incorporated. The company was founded in 1990 and is headquartered in Venissieux, France.

SMART BALANCE INC (NASDAQ:SMBL) - Smart Balance, Inc. distributes various food products in the United States and internationally. The company offers its products under the Smart Balance and Earth Balance trademarks. Its Smart Balance brand products include buttery spreads and butter blend sticks, peanut butter, cooking oil and cooking sprays, omega plus light mayonnaise, popcorn, milk, and sour cream; and Earth Balance brand products comprise buttery spreads and sticks, and nut butters formulated for consumers interested in natural and organic products. The company also markets its Earth Balance products under the Soy Garden and Natucal trademarks. Smart Balance sells its products primarily through supermarket chains; food wholesalers; and grocery, mass merchandise, and convenience stores, as well as through independent food and beverage distributors. The company is headquartered in Paramus, New Jersey.

ALASKA COMM SYSTEMS GROUP (NASDAQ:ALSK) - Alaska Communications Systems Group, Inc., through its subsidiaries, provides integrated communications services in the State of Alaska. It operates in two segments, Wireline and Wireless. The Wireline segment provides voice, data, broadband, multi-protocol label switching services, network access, long distance, and other services to consumers, carriers, businesses and enterprises, and government customers. This segment also offers other telecommunications carriers voice and data services, such as private line, frame relay, and ATM services; and voice and data termination services to long distance and other carriers through its local telephone facilities. The Wireless segment provides facilities-based voice and data services; and equipment sales. This segment, through roaming agreements with the U.S. and Canadian carriers, provides its customers a range of services and coverage in the lower 48 states, Hawaii, and Canada. As of December 31, 2009, the company served approximately 137,000 subscribers and 186,000 access lines. Alaska Communications Systems Group, Inc. was founded in 1998 and is based in Anchorage, Alaska.

LOGMEIN INC (NASDAQ:LOGM) - LogMeIn, Inc. provides on-demand, remote-connectivity solutions to small and medium-sized businesses, information technology (IT) service providers, and consumers in the United States and internationally. Its services include remote user access services, which allow users to access computers and other Internet-enabled devices to continue working while away from the office or to access personal systems while away from home; and remote support and management services that are used by internal IT departments, and external service and support organizations to deliver support and management of IT resources remotely. The companys remote user access services comprise LogMeIn Free, a free remote access service; LogMeIn Pro, a premium remote access service; LogMeIn Hamachi, a hosted virtual private network service that sets up a computer network among remote computers; and LogMeIn Ignition, a premium service that delivers access to remote computers, which subscribe to LogMeIn Free and LogMeIn Pro. Its remote support and management services include LogMeIn Rescue, a Web-based remote support service to support remote computers and applications, and assist computer users via the Internet; LogMeIn Rescue+Mobile, an extension of LogMeIn Rescues Web-based remote support service to remotely access and support smartphones; LogMeIn Central, a Web-based management console; and LogMeIn Backup, a service that subscribers install on two or more computers to create a backup network. The companys solutions are used by businesses and IT service providers to deliver end-user support, and to remotely access and manage computers and other Internet-enabled devices; and used by consumers and mobile workers to access computer resources remotely. It has a strategic agreement with Intel Corporation. The company was formerly known as 3am Labs, Inc. and changed its name to LogMeIn, Inc. in March 2006. LogMeIn, Inc. was founded in 2003 and is headquartered in Woburn, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641